title: In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene.
abstract: BACKGROUND
  Inflammatory breast cancer (IBC) is a rare, highly aggressive form of breast cancer. The mechanism of IBC carcinogenesis remains unknown. We sought to evaluate potential genetic risk factors for IBC and whether or not the IBC cell lines SUM149 and SUM190 demonstrated evidence of viral infection.
  
  
  METHODS
  We performed single nucleotide polymorphism (SNP) genotyping for 2 variants of the ribonuclease (RNase) L gene that have been correlated with the risk of prostate cancer due to a possible viral etiology. We evaluated dose-response to treatment with interferon-alpha (IFN-α); and assayed for evidence of the putative human mammary tumor virus (HMTV, which has been implicated in IBC) in SUM149 cells. A bioinformatic analysis was performed to evaluate expression of RNase L in IBC and non-IBC.
  
  
  RESULTS
  2 of 2 IBC cell lines were homozygous for RNase L common missense variants 462 and 541; whereas 2 of 10 non-IBC cell lines were homozygous positive for the 462 variant (p= 0.09) and 0 of 10 non-IBC cell lines were homozygous positive for the 541 variant (p = 0.015). Our real-time polymerase chain reaction (RT-PCR) and Southern blot analysis for sequences of HMTV revealed no evidence of the putative viral genome.
  
  
  CONCLUSIONS
  We discovered 2 SNPs in the RNase L gene that were homozygously present in IBC cell lines. The 462 variant was absent in non-IBC lines. Our discovery of these SNPs present in IBC cell lines suggests a possible biomarker for risk of IBC. We found no evidence of HMTV in SUM149 cells. A query of a panel of human IBC and non-IBC samples showed no difference in RNase L expression. Further studies of the RNase L 462 and 541 variants in IBC tissues are warranted to validate our in vitro findings.
authors: 1. University of Arizona Cancer Center;
authors: Brandon T
authors: BT
authors: Nokes
authors: Heather E
authors: HE
authors: Cunliffe
authors: Bonnie
authors: B
authors: Lafleur
authors: David W
authors: DW
authors: Mount
authors: Robert B
authors: RB
authors: Livingston
authors: Bernard W
authors: BW
authors: Futscher
authors: Julie E
authors: JE
authors: Lang
keywords: HMTV; MMTV; RNase L.; SUM149; inflammatory breast cancer; interferon-alpha
references: Ann Intern Med. 1996 Jan 1;124(1 Pt 1):27-30
references: 7503474
references: Arch Surg. 2006 Jun;141(6):567-72; discussion 572-3
references: 16785357
references: BMC Cancer. 2005 Oct 22;5:137
references: 16242046
references: Clin Cancer Res. 1999 Aug;5(8):2108-11
references: 10473094
references: Breast Cancer Res. 2006;8(4):212
references: 16887003
references: Am J Hum Genet. 2002 May;70(5):1299-304
references: 11941539
references: Genet Epidemiol. 2003 Sep;25(2):136-48
references: 12916022
references: J Natl Cancer Inst. 2005 Jul 6;97(13):966-75
references: 15998949
references: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):474-84
references: 18439768
references: Int J Cancer. 2003 Aug 10;106(1):138; author reply 139
references: 12794768
references: Mutat Res. 2005 Jun 3;573(1-2):111-35
references: 15829242
references: Science. 2011 Jan 7;331(6013):17
references: 21212329
references: J Virol Methods. 2010 Jan;163(1):157-61
references: 19781575
references: Cancer Res. 1993 Feb 1;53(3):627-35
references: 8425198
references: Cancer. 2010 Jun 1;116(11 Suppl):2741-4
references: 20503403
references: Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6215-21
references: 15448010
references: Breast Cancer Res. 2005;7(2):52-8
references: 15743511
references: Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
references: 11585785
references: Biostatistics. 2008 Apr;9(2):201-15
references: 17873152
references: Oncologist. 2007 Aug;12(8):904-12
references: 17766649
references: Cancer. 2010 Jun 1;116(11 Suppl):2837-9
references: 20503416
references: Cancer Cell Int. 2005 Apr 27;5(1):11
references: 15857504
references: Br J Cancer. 1999 Dec;81(8):1328-34
references: 10604729
references: Curr Opin Oncol. 2006 Nov;18(6):563-71
references: 16988576
references: Retrovirology. 2010 Dec 20;7:112
references: 21171980
references: PLoS Pathog. 2006 Mar;2(3):e25
references: 16609730
references: Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):381-8
references: 17681844
references: Int J Cancer. 2008 Jun 15;122(12):2864-70
references: 18348144
references: Breast Cancer Res Treat. 2011 Jan;125(1):295-7
references: 20872240
references: Oncology (Williston Park). 2008 Dec;22(14):1556-61; discussion 1561, 1565-8, 1576
references: 19198217
references: Ann Oncol. 2011 Mar;22(3):515-523
references: 20603440
references: Science. 1977 Jun 24;196(4297):1456-8
references: 867042
references: J Natl Compr Canc Netw. 2011 Feb;9(2):233-40; quiz 241
references: 21310844
references: J Clin Oncol. 2011 Mar 10;29(8):1014-21
references: 21220618
references: Infect Agent Cancer. 2006 Dec 15;1:7
references: 17173685
references: J Virol. 2007 Dec;81(23):12720-9
references: 17804500
references: Cancer Res. 2012 Jul 15;72(14):3445-50
references: 22761333
references: Int J Cancer. 2008 Mar 15;122(6):1324-32
references: 17999412
references: Clin Cancer Res. 2004 Sep 1;10(17):5647-9
references: 15355888
references: Mol Biol Evol. 2012 Oct;29(10):3161-8
references: 22513284
references: Infect Agent Cancer. 2008 Feb 28;3:2
references: 18307792
references: J Gen Virol. 2007 Jun;88(Pt 6):1806-1809
references: 17485542
references: Breast Cancer Res Treat. 2011 Jan;125(1):229-35
references: 20512660
references: Clin Cancer Res. 2007 Oct 1;13(19):5959-64
references: 17908993
references: Annu Rev Microbiol. 2001;55:255-81
references: 11544356
references: CA Cancer J Clin. 2010 Nov-Dec;60(6):351-75
references: 20959401
references: Semin Oncol. 2008 Feb;35(1):41-50
references: 18308145
references: Semin Oncol. 2008 Feb;35(1):7-10
references: 18308140